Young Mo Kang
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
- Rheumatology 44
- Rheumatoid Arthritis Research and Therapies 21
- Systemic Lupus Erythematosus Research 17
- Spondyloarthritis Studies and Treatments 6
- Immunology 21
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 5
- Co-authors
- Jae Hyung Park (18 shared papers)Dong‐Gyu Jo (8 shared papers)Won Kee Lee (15 shared papers)Ki Young Choi (4 shared papers)Eon Jeong Nam (29 shared papers)Jörg J. Goronzy (4 shared papers)Ick Chan Kwon (4 shared papers)Seung Woo Han (14 shared papers)
- Journals
- Annals of the Rheumatic Diseases (12 papers)Journal of Korean Medical Science (6 papers)Journal of Controlled Release (5 papers)Arthritis Research & Therapy (4 papers)PLoS ONE (3 papers)
- Partner nations
- South KoreaUnited StatesSingapore
In The Last Decade
Young Mo Kang
108 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 130
- Rheumatology 732
- Biomaterials 579
- Immunology 576
- Pharmaceutical Science 143
- Cancer Research 289
Countries citing papers authored by Young Mo Kang
This map shows the geographic impact of Young Mo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Mo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Mo Kang more than expected).
Fields of papers citing papers by Young Mo Kang
This network shows the impact of papers produced by Young Mo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Mo Kang. The network helps show where Young Mo Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Young Mo Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 338 | |
| 2 | 2016 | 162 | |
| 3 | 2002 | 148 | |
| 4 | 2017 | 144 | |
| 5 | 2005 | 118 | |
| 6 | 2011 | 115 | |
| 7 | 2015 | 106 | |
| 8 | 2015 | 102 | |
| 9 | 2007 | 93 | |
| 10 | 2017 | 87 | |
| 11 | 2006 | 84 | |
| 12 | 2004 | 79 | |
| 13 | 2015 | 79 | |
| 14 | 2012 | 78 | |
| 15 | 2013 | 72 | |
| 16 | 2005 | 67 | |
| 17 | 2011 | 67 | |
| 18 | 2013 | 58 | |
| 19 | 2019 | 56 | |
| 20 | 2006 | 54 |
About Young Mo Kang
Young Mo Kang is a scholar working on Rheumatology, Immunology, Molecular Biology, Oncology and Cancer Research, having authored 111 papers that have together received 3.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (21 papers), Systemic Lupus Erythematosus Research (17 papers), Cell Adhesion Molecules Research (9 papers), Nanoparticle-Based Drug Delivery (9 papers), T-cell and B-cell Immunology (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Spondyloarthritis Studies and Treatments (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Rheumatology (732 citations), Biomaterials (579 citations), Immunology (576 citations), Pharmaceutical Science (143 citations) and Cancer Research (289 citations). Young Mo Kang has collaborated with scholars based in South Korea, United States and Singapore. Frequent co-authors include Jae Hyung Park, Dong‐Gyu Jo, Won Kee Lee, Ki Young Choi, Eon Jeong Nam, Jörg J. Goronzy, Ick Chan Kwon, Seung Woo Han, Hyewon Ko and Hwa Seung Han. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of Korean Medical Science, Journal of Controlled Release, Arthritis Research & Therapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.